Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verve Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $4.16 | Jul 25, 2025 | By GV 2017 L.P. |
Verve Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $4.16 | Jul 25, 2025 | By GV 2019 L.P. |
Verve Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $4.16 | Jul 25, 2025 | By GV 2023, L.P. |
EQRx, Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 9, 2023 | Direct | ||
Verve Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 0 | Jul 25, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VERV | Verve Therapeutics, Inc. | Jul 25, 2025 | 5 | $0 | 4 | Jul 28, 2025 | Director, 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 5, 2025 | 1 | $0 | 4 | Jun 6, 2025 | Director, 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Director, 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Dec 1, 2023 | 1 | $18M | 4 | Dec 5, 2023 | Director, 10%+ Owner |
EQRX | EQRx, Inc. | Nov 9, 2023 | 1 | $0 | 4 | Nov 9, 2023 | Director |
VERV | Verve Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director, 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Nov 4, 2022 | 4 | -$1.51M | 4 | Nov 8, 2022 | Director, 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Nov 2, 2022 | 8 | -$2.66M | 4 | Nov 4, 2022 | Director, 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Oct 31, 2022 | 9 | -$3.25M | 4 | Nov 2, 2022 | Director, 10%+ Owner |
EQRX | EQRx, Inc. | Sep 30, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
VERV | Verve Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director, 10%+ Owner |
EQRX | EQRx, Inc. | Dec 17, 2021 | 0 | $0 | 3 | Dec 20, 2021 | Director |
VERV | Verve Therapeutics, Inc. | Jun 21, 2021 | 6 | $0 | 4 | Jun 22, 2021 | Director, 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director, 10%+ Owner |